Related Experiment Video
Updated: Mar 24, 2026
10:10
Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity
Published on: November 8, 2016
9.3K
Dendritic Cell-based Immunotherapy for Rheumatoid Arthritis: from Bench to Bedside
Md Selim Ahmed1, Yong-Soo Bae1
1Department of Biological Science, Sungkyunkwan University, Suwon 16419, Korea.
Immune Network
|March 4, 2016
Summary
Tolerogenic dendritic cells (tolDCs) show promise for treating rheumatoid arthritis (RA). Research is evolving, with several clinical trials underway for this immunotherapy approach.
Area of Science:
- Immunology
- Rheumatology
Background:
- Dendritic cells (DCs) are key antigen-presenting cells crucial for adaptive immunity.
- Certain DC populations regulate immune responses and maintain homeostasis.
- Tolerogenic DCs (tolDCs) can be generated through various in vitro methods.
Purpose of the Study:
- To review the development of tolDC-based immunotherapy for rheumatoid arthritis (RA).
- To discuss the limitations and future directions of tolDC therapy in RA treatment.
Main Methods:
- Review of in vitro and in vivo studies on tolDCs for RA.
- Analysis of clinical trial data and progress up to 2015.
- Discussion of methods for generating tolDCs.
Main Results:
- tolDCs have been investigated in experimental animal models for RA.
- Several in vitro and in vivo approaches have progressed to clinical trials.
- As of 2015, three tolDC trials for RA were registered on ClinicalTrials.gov.
Conclusions:
- tolDC-based immunotherapy represents an evolving treatment strategy for RA.
- Further clinical trials are anticipated to assess efficacy and safety.
- Understanding tolDC generation and function is critical for advancing RA treatment.
Related Concept Videos
01:24T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
657
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
657
01:27Tumor Immunotherapy
2.2K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.2K